Fan Ting-Jun, Hu Xiu-Zhong, Zhao Jun, Niu Ying, Zhao Wen-Zhuo, Yu Miao-Miao, Ge Yuan
Key Laboratory for Corneal Tissue Engineering, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, Shandong Province, China.
Int J Ophthalmol. 2012;5(3):286-92. doi: 10.3980/j.issn.2222-3959.2012.03.07. Epub 2012 Jun 18.
To establish an untransfected human corneal stromal (HCS) cell line and characterize its biocompatibility to acellular porcine corneal stroma (aPCS).
Primary culture was initiated with a pure population of HCS cells in DMEM/F12 media (pH 7.2) containing 20% fetal bovine serum and various necessary growth factors. The established cell line was characterized by growth property, chromosome analysis, tumorigenicity assay, expression of marker proteins and functional proteins. Furthermore, the biocompatibility of HCS cells with aPCS was examined through histological and immunocytochemistry analyses and with light, electron microscopies.
HCS cells proliferated to confluence 2 weeks later in primary culture and have been subcultured to passage 140 so far. A continuous untransfected HCS cell line with a population doubling time of 41.44 hours at passage 80 has been determined. Results of chromosome analysis, morphology, combined with the results of expression of marker protein and functional proteins suggested that the cells retained HCS cell properties. Furthermore, HCS cells have no tumorigenicity, and with excellent biocompatibility to aPCS.
An untransfected and non-tumorigenic HCS cell line has been established, and the cells maintained positive expression of marker proteins and functional proteins. The cell line, with excellent biocompatibility to aPCS, might be used for in vitro reconstruction of tissue-engineered HCS.
建立未转染的人角膜基质(HCS)细胞系,并表征其对脱细胞猪角膜基质(aPCS)的生物相容性。
在含有20%胎牛血清和各种必要生长因子的DMEM/F12培养基(pH 7.2)中,以纯的HCS细胞群体开始原代培养。通过生长特性、染色体分析、致瘤性测定、标记蛋白和功能蛋白的表达对建立的细胞系进行表征。此外,通过组织学和免疫细胞化学分析以及光镜和电镜检查HCS细胞与aPCS的生物相容性。
HCS细胞在原代培养2周后增殖至汇合,迄今为止已传代至第140代。已确定在第80代时群体倍增时间为41.44小时的连续未转染HCS细胞系。染色体分析、形态学结果,结合标记蛋白和功能蛋白的表达结果表明这些细胞保留了HCS细胞特性。此外,HCS细胞无致瘤性,并且对aPCS具有优异的生物相容性。
已建立未转染且无致瘤性的HCS细胞系,并且这些细胞维持标记蛋白和功能蛋白的阳性表达。该细胞系对aPCS具有优异的生物相容性,可用于组织工程化HCS的体外重建。